Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Piperonyl Butoxide, Pyrethrins
Bob Martin (UK) Ltd
amended)
Piperonyl Butoxide, Pyrethrins
Expired
Revised: February 2010 (ATCVet code amended) 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bob Martin Flea Cutaneous Powder for Cats & Dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE(S) Pyrethrum Powder 1.3% (Equivalent to pyrethrins……………………. Piperonyl Butoxide………………………..... EXCIPIENTS Butylated hydroxytoluene…………………... For full list of excipients, see section 6.1 % W/W 7.78 0.10) 0.80 0.05 3. PHARMACEUTICAL FORM Cutaneous powder. Light grey, free flowing powder with characteristic odour. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cat and dog. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES. To kill fleas on cats and dogs over 12 weeks of age. 4.3 CONTRAINDICATIONS i) Do not use on puppies or kittens under 12 weeks of age. ii) Do not use on nursing females. iii) 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Revised: February 2010 (ATCVet code amended) 4.5 SPECIAL PRECAUTIONS FOR USE i. a) For external use only. b) Avoid the animal’s eyes. ii. SPECIAL PRECAUTIONS FOR THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Avoid inhaling the powder. Use in a well ventilated area. Wash hands and exposed skin after use. Avoid contact with eyes. In case of accidental eye contact, rinse with clean, fresh water. If eye irritation persists, seek medical advice. Persons who are hypersensitive (allergic) to pyrethrum extract should handle the product with care. Keep away from food and drink, including animal feedingstuffs. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Adverse reactions to this product are very rare (< 0.001% of unit sales) with no pattern of signs established. 4.7 USE DURING PREGNANCY, LACTATION OR LAY a) Do not use on nursing females. b) Remove fleas from young puppies, kittens and nursi Read the complete document